Proteomic Technologies for the Study of Osteosarcoma

Abstract EN

Osteosarcoma is the most common primary bone cancer of children and is established during stages of rapid bone growth.

The disease is a consequence of immature osteoblast differentiation, which gives way to a rapidly synthesized incompletely mineralized and disorganized bone matrix.

The mechanism of osteosarcoma tumorogenesis is poorly understood, and few proteomic studies have been used to interrogate the disease thus far.

Accordingly, these studies have identified proteins that have been known to be associated with other malignancies, rather than being osteosarcoma specific.

In this paper, we focus on the growing list of available state-of-the-art proteomic technologies and their specific application to the discovery of novel osteosarcoma diagnostic and therapeutic targets.

The current signaling markers/pathways associated with primary and metastatic osteosarcoma that have been identified by early-stage proteomic technologies thus far are also described.